Acta gastro-enterologica Belgica, vol.79, no.1, pp.18-22, 2016 (SCI-Expanded)
Background/Aims : Patients with genotype 1 chronic hepatitis C virus (HCV) who do not have a sustained virologic response to therapy with peginterferon alfa and ribavirin have a low likelihood of success with retreatment.